ASX - By Stock
|
FLC |
Re:
Media Update
|
|
ocyc
|
3.5K |
2.4M |
7 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
3.5K
|
2.4M
|
7
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
ocyc
|
3.3K |
2.5M |
7 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
ocyc
|
98 |
38K |
11 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
98
|
38K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Dartford and Gravesham NHS Trust to pilot ResAppDx
|
|
ocyc
|
40 |
14K |
0 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
40
|
14K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Patience
|
|
ocyc
|
18 |
5.1K |
25 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
18
|
5.1K
|
25
|
|
ASX - By Stock
|
FLC |
Re:
Chart
|
|
ocyc
|
1.0K |
376K |
1 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
1.0K
|
376K
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Media Update
|
|
ocyc
|
3.5K |
2.4M |
21 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
3.5K
|
2.4M
|
21
|
|
ASX - By Stock
|
FLC |
Re:
Ann: FLC Commissions First MABR Installation in Cambodia
|
|
ocyc
|
108 |
39K |
22 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
108
|
39K
|
22
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces FDA 510(k) submission for SleepCheckRx
|
|
ocyc
|
74 |
25K |
1 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
74
|
25K
|
1
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Customer update (NanoDX)
|
|
ocyc
|
145 |
42K |
8 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
145
|
42K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
ocyc
|
3.3K |
2.5M |
20 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
20
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResAppDx receives regulatory approval in Indonesia
|
|
ocyc
|
60 |
21K |
26 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
60
|
21K
|
26
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Alodokter to launch ResAppDx in Indonesia
|
|
ocyc
|
387 |
102K |
63 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
387
|
102K
|
63
|
|
ASX - By Stock
|
FLC |
Re:
Chart
|
|
ocyc
|
1.0K |
376K |
7 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
1.0K
|
376K
|
7
|
|
ASX - By Stock
|
FLC |
Re:
Media Update
|
|
ocyc
|
3.5K |
2.4M |
21 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
3.5K
|
2.4M
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Brian Leedman Reappointed as Executive Director
|
|
ocyc
|
63 |
21K |
35 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
63
|
21K
|
35
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Announces Key Orders In China and SE Asia
|
|
ocyc
|
70 |
24K |
32 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
70
|
24K
|
32
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
ocyc
|
130 |
46K |
43 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
130
|
46K
|
43
|
|
ASX - By Stock
|
RAP |
Re:
RAP/DOC
|
|
ocyc
|
97 |
21K |
39 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
97
|
21K
|
39
|
|
Charts
|
FLC |
Re:
Chart
|
|
ocyc
|
8.0K |
3.5M |
3 |
03/12/20 |
03/12/20 |
Charts
|
8.0K
|
3.5M
|
3
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Strategic Repositioning, Change in CEO
|
|
ocyc
|
100 |
30K |
18 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
100
|
30K
|
18
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Strategic Repositioning, Change in CEO
|
|
ocyc
|
100 |
30K |
6 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
100
|
30K
|
6
|
|
ASX - By Stock
|
FLC |
Re:
FLC Top 20 Holders
|
|
ocyc
|
228 |
204K |
11 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
228
|
204K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: AstraZeneca to use new ResApp software in clinical study
|
|
ocyc
|
121 |
38K |
63 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
121
|
38K
|
63
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Business Update Reaffirm Guidance
|
|
ocyc
|
52 |
18K |
5 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
52
|
18K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Results and Investor Conference Call Notification
|
|
ocyc
|
296 |
89K |
58 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
296
|
89K
|
58
|
|
Charts
|
FLC |
Re:
Chart
|
|
ocyc
|
8.0K |
3.5M |
9 |
19/06/20 |
19/06/20 |
Charts
|
8.0K
|
3.5M
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Receives Final Design Files for Hardware Devices
|
|
ocyc
|
207 |
63K |
15 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
207
|
63K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Receives Final Design Files for Hardware Devices
|
|
ocyc
|
207 |
63K |
10 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
207
|
63K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
ocyc
|
57 |
20K |
15 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
57
|
20K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Coviu and ResApp Complete Initial ResAppDx-EU Integration
|
|
ocyc
|
314 |
148K |
24 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
314
|
148K
|
24
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Coviu and ResApp Complete Initial ResAppDx-EU Integration
|
|
ocyc
|
314 |
148K |
2 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
314
|
148K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Telehealth on the rise
|
|
ocyc
|
3.0K |
11M |
7 |
26/03/20 |
26/03/20 |
ASX - By Stock
|
3.0K
|
11M
|
7
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Investor Presentation February / March 2020
|
|
ocyc
|
39 |
1.5M |
9 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
39
|
1.5M
|
9
|
|
ASX - By Stock
|
RAP |
Re:
2020 The Year Of RAP
|
|
ocyc
|
1.3K |
1.2M |
26 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
1.3K
|
1.2M
|
26
|
|
ASX - By Stock
|
RAP |
Re:
Coronavirus spread in China
|
|
ocyc
|
93 |
87K |
5 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
93
|
87K
|
5
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Trading Halt
|
|
ocyc
|
121 |
43K |
1 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
121
|
43K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
T/O PRICE
|
|
ocyc
|
14 |
10K |
7 |
24/01/20 |
24/01/20 |
ASX - By Stock
|
14
|
10K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
2020 The Year Of RAP
|
|
ocyc
|
1.3K |
1.2M |
29 |
23/01/20 |
23/01/20 |
ASX - By Stock
|
1.3K
|
1.2M
|
29
|
|
ASX - By Stock
|
RAP |
Re:
2020 The Year Of RAP
|
|
ocyc
|
1.3K |
1.2M |
22 |
15/01/20 |
15/01/20 |
ASX - By Stock
|
1.3K
|
1.2M
|
22
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Ivory Coast Project Finance Agreements Awaiting Execution
|
|
ocyc
|
53 |
26K |
5 |
02/01/20 |
02/01/20 |
ASX - By Stock
|
53
|
26K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Coviu & ResApp
|
|
ocyc
|
144 |
72K |
14 |
04/12/19 |
04/12/19 |
ASX - By Stock
|
144
|
72K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of Annual General Meeting
|
|
ocyc
|
170 |
88K |
54 |
03/12/19 |
03/12/19 |
ASX - By Stock
|
170
|
88K
|
54
|
|
ASX - By Stock
|
FLC |
Re:
Media Update
|
|
ocyc
|
3.5K |
2.4M |
20 |
13/11/19 |
13/11/19 |
ASX - By Stock
|
3.5K
|
2.4M
|
20
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Receives US$3m Follow-On Aspiral Order from ITEST
|
|
ocyc
|
11 |
9.0K |
9 |
01/11/19 |
01/11/19 |
ASX - By Stock
|
11
|
9.0K
|
9
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Receives US$3m Follow-On Aspiral Order from ITEST
|
|
ocyc
|
11 |
9.0K |
12 |
01/11/19 |
01/11/19 |
ASX - By Stock
|
11
|
9.0K
|
12
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence June 2019 Quarterly Report Business Update
|
|
ocyc
|
149 |
49K |
14 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
149
|
49K
|
14
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence June 2019 Quarterly Report Business Update
|
|
ocyc
|
149 |
49K |
16 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
149
|
49K
|
16
|
|
ASX - By Stock
|
FLC |
Re:
FLC - Game On
|
|
ocyc
|
16 |
10K |
12 |
14/07/19 |
14/07/19 |
ASX - By Stock
|
16
|
10K
|
12
|
|
Charts
|
FLC |
Re:
Chart
|
|
ocyc
|
8.0K |
3.5M |
25 |
06/07/19 |
06/07/19 |
Charts
|
8.0K
|
3.5M
|
25
|
|